BiotechTube
Home/Opna Bio/Dov Gal, Esq.
DG

Dov Gal, Esq.

VP, Administration and Associate General Counsel

Opna Bio

Therapeutic Areas

OncologyImmunology

Opna Bio Pipeline

DrugIndicationPhase
Zavabresib (OPN-2853)MyelofibrosisPhase 1
OPN-6602Multiple MyelomaPhase 1
Multi-functional DegradersMyeloma and LymphomaPreclinical
OPN-FMRPSolid TumorsResearch

Leadership Team at Opna Bio

GB
Gideon Bollag, PhD
Cofounder and Chief Scientific Officer
RD
Reinaldo Diaz, MBA
Chief Executive Officer
JW
Jackie Walling, MBChB, PhD
Chief Medical Officer
SB
Stuart Barlow, MBA, CPA
Chief Accounting Officer
View full Opna Bio profile